Skip to main content
Clinical Trials/KCT0003825
KCT0003825
Not yet recruiting
未知

Cryoballoon pulmonary vein isolation vs. Radiofrequency pulmonary vein isolation with additional right atrial linear ablation for Valvular atrial fibrillation: Prospective randomized trial (CRAVA Trial)

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
154
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with hemodynamic corrected valvular atrial fibrillation who is scheduled for ablation procedure and \=20 and \=80 years of age
  • 2\. Left atrium size \< 50mm
  • 3\. paroxysmal atrial fibrillation that is reccurrence during antiarrhythmic drug treatment or is not able to use an antiarrhythmic drug.
  • 4\. Patient who is indicated for anticoagulation therapy (for prevention of cerebral infarction)

Exclusion Criteria

  • 1\. Patients with permanent atrial fibrillation
  • 2\. Atrial fibrillation associated with severe cardiac malformation or a structural heart disease that is hemodynamically affected
  • 3\. Patients with severe renal impairment or CT imaging difficulty using contrast media
  • 4\. Patients with a past history of radiofrequency ablation for atrial fibrillation or other cardiac surgery
  • 5\. Patients with active internal bleeding
  • 6\. Patients with contraindications for anticoagulation therapy(for prevention of cerebral infarction) and antiarrhythmic drugs
  • 7\. Patients with non\-valvular atrial fibrillation
  • 8\. Patients with a severe comorbid disease
  • 9\. Expected survival \< 1 year
  • 10\. Drug addicts or alcoholics

Outcomes

Primary Outcomes

Not specified

Similar Trials